Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rhythm Biosciences Ltd. ( (AU:RHY) ) has provided an update.
Rhythm Biosciences Ltd. has announced a proposed issue of 483,871 ordinary fully paid securities, with the issue date set for June 2, 2025. This move is part of a placement or other type of issue, which could potentially enhance the company’s capital structure, providing additional resources for its operations and strategic initiatives in the biotechnology sector.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development of diagnostic technologies. The company is primarily engaged in creating products aimed at early detection and monitoring of cancer, with a market focus on improving patient outcomes through innovative diagnostic solutions.
Average Trading Volume: 232,721
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$18.84M
For an in-depth examination of RHY stock, go to TipRanks’ Stock Analysis page.